“[...] this study addresses a critical gap by providing new insights into the role of telomere attrition across different progeroid conditions.” “[…] this ...

Researchers at the Salk Institute and King Abdullah University of Science and Technology (KAUST) in Saudi Arabia say they have discovered that a DNA segment that jumps around the human genome plays a ...

“Progeroid syndromes (PS) are a heterogeneous group of rare hereditary disorders with features resembling premature aging.” The study was led by Nuša Likar and Tanja Kunej from the University of ...

A stretch of DNA that hops around the human genome plays a role in premature aging disorders, scientists have discovered. In people with early aging, or progeria, RNA encoded by this mobile DNA builds ...

The researchers say their findings point to a new avenue for the possible treatment of premature aging and may also be relevant to other aging-associated pathologies. Progeroid syndromes, such as ...

A stretch of DNA that hops around the human genome plays a role in premature aging disorders, scientists at the Salk Institute and King Abdullah University of Science and Technology (KAUST) in Saudi ...

UT Southwestern researchers have discovered a new form of progeria, a rare premature-aging syndrome, in a man from Malaysia and traced its cause to a novel gene mutation. The finding, reported in the ...

Werner's syndrome (WS) is a rare autosomal recessive disorder, one of the progeroid syndromes, characterized by features of premature aging. The genetic defect in WS is unknown but recently the ...

Zokinvy works by preventing farnesylation and subsequent accumulation of progerin and progerin-like proteins in the inner nuclear membrane. The most common adverse reactions (incidence greater than or ...

PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare ...

PALO ALTO, Calif., May 19, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare ...